Amiodarone in atrial fibrillation

International Journal of Clinical Practice

Volumn 52, Issue 6, 1998, Pages 429-431

  Levy, S ^a  

^a HÔPITAL NORD   (France)

Author keywords

[No Author keywords available]

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; QUINIDINE;

CARDIOVERSION; DRUG SAFETY; HEART ATRIUM FIBRILLATION; HEART FAILURE; HUMAN; LUNG FIBROSIS; ORAL DRUG ADMINISTRATION; PHOTOSENSITIVITY; PRIORITY JOURNAL; RECURRENT DISEASE; SHORT SURVEY; THYROID DISEASE;

ADMINISTRATION, ORAL; AMIODARONE; ANTI-ARRHYTHMIA AGENTS; ATRIAL FIBRILLATION; ELECTRIC COUNTERSHOCK; HEART FAILURE, CONGESTIVE; HUMANS; RECURRENCE;

EID: 0031705713     PISSN: 13685031     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Short Survey

References (22)

1. Cabin HS, Clubb KS, Hall C et al. Risk for systemic embolisation of atrial fibrillation without mitral stenosis. Am J Cardiol 1990; 61: 714-717.
2. Middlekauff HR, Stevenson WG, Stevenson LW. Prognostic significance of atrial fibrillation in advanced heart failure. Circulation 1991; 84: 40-48.
3. Rawles J. Atrial fibrillation. Berlin: Springer-Verlag 1992; 181-197.
4. Charlier R, Deitour G. Correction des arythmies experimentales par l'amiodarone. J Pharmacologie 1970; 1: 175.
5. The Cardiac Arrhythmia Suppression Trial (CAST) Investigators. Preliminary report: effect of encainide and flecainide on mortality in a randomised trial of arrhythmia suppression after myocardial infarction. N Engl J Med 1989; 10: 406-412.
6. Coplen SE, Antman EM, Berlin JA et al. Efficacy and safety of quinidine therapy for maintenance of sinus rhythm after cardioversion: a meta-analysis of randomised control trials. Circulation 1990; 82: 1106-1116.
7. Flaker GC, Blackshear JL, McBride R et al. Antiarrhythmic drug therapy and cardiac mortality in atrial fibrillation. J Am Coll Cardiol 1992; 20: 527-532.
8. Mostow ND, Vrobel TR, Noon D, Rakita L. Rapid control of refractory atrial tachyarrhythmias with high-dose oral amiodarone. Am Heart J 1990; 120: 1356-1363.
9. Skoularigis J, Tothlisberge C, Skudicky D et al. Effectiveness of amiodarone and electrical cardioversion for chronic rheumatic atrial fibrillation after mitral valve surgery. Am J Cardiol 1992; 20: 527-532.
10. Coumel P, Attuel P, Lavallee JP et al. Syndrome d'arythmie auriculaire d'origine vagale. Arch Mal Coeur 1978; 71: 645-656.
11. Levy S, Lauribe Ph, Dolla E et al. A randomised comparison of external and internal cardioversion of chronic atrial fibrillation. Circulation 1992; 86: 1415-1420.
12. Lundstrom T, Ryden L. Ventricular rate control and exercise performance in chronic atrial fibrillation: effects of diltiazem and verapamil. J Am Coll Cardiol 1990; 16: 86-90.
13. Feld GK. Atrial fibrillation: is there a safe and highly effective pharmacological treatment? Circulation 1990; 82: 2248-2250.
14. Vitolo E, Tronci M, Larovere MT et al. Amiodarone versus quinidine in the prophylaxis of atrial fibrillation. Acta Cardiol 1981; 36: 431-444.
15. Gosselink ATM, Crijns SGM, Van Gelder IC et al. Low-dose amiodarone for maintenance of sinus rhythm after cardioversion of atrial fibrillation or flutter. JAMA 1992; 267: 3289-3293.
16. Chun SH, Sager PhT, Stevenson WG et al. Long-term efficacy of amiodarone for the maintenance of normal sinus rhythm in patients with refractory atrial fibrillation or flutter. Am J Cardiol 1995; 76: 47-50.
17. Levy S. Novella P, Ricard Ph, Paganelli F. Paroxysmal atrial fibrillation: a need for classification. J Cardiovasc Electrophysiol 1995; 6: 69-74.
18. Gold RL, Haffajee Cl, Charos G et al. Amiodarone for refractory atrial fibrillation. Am J Cardiol 1986; 57: 124-127.
19. Graboys TB, Podrid PJ, Lown B. Efficacy of amiodarone for refractory supraventricular tachyarrhythmias. Am Heart J 1983; 106: 870-876.
20. Haffajee CI, Love JC, Canada AT et al. Clinical pharmacokinetics and efficacy of amiodarone for refractory tachyarrhythmias. Circulation 1983; 67: 1347-1355.
21. Singh SN, Fletcher RD, Gross Fisher S et al. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. N Engl J Med 1995; 33: 77-82.
22. Dusman RE, Stanton MS, Miles WM et al. Clinical features of amiodarone induced pulmonary toxicity. Circulation 1990; 82: 51-59.